144 related articles for article (PubMed ID: 37852044)
1. Degeneration of cholinergic white matter pathways and nucleus basalis of Meynert in individuals with objective subtle cognitive impairment.
Qiu T; Hong H; Zeng Q; Luo X; Wang X; Xu X; Xie F; Li X; Li K; Huang P; Dai S; Zhang M;
Neurobiol Aging; 2023 Dec; 132():198-208. PubMed ID: 37852044
[TBL] [Abstract][Full Text] [Related]
2. Cholinergic white matter pathways in dementia with Lewy bodies and Alzheimer's disease.
Schumacher J; Ray NJ; Hamilton CA; Donaghy PC; Firbank M; Roberts G; Allan L; Durcan R; Barnett N; O'Brien JT; Taylor JP; Thomas AJ
Brain; 2022 Jun; 145(5):1773-1784. PubMed ID: 34605858
[TBL] [Abstract][Full Text] [Related]
3. Cholinergic white matter pathways make a stronger contribution to attention and memory in normal aging than cerebrovascular health and nucleus basalis of Meynert.
Nemy M; Cedres N; Grothe MJ; Muehlboeck JS; Lindberg O; Nedelska Z; Stepankova O; Vyslouzilova L; Eriksdotter M; Barroso J; Teipel S; Westman E; Ferreira D
Neuroimage; 2020 May; 211():116607. PubMed ID: 32035186
[TBL] [Abstract][Full Text] [Related]
4. Cholinergic white matter pathways along the Alzheimer's disease continuum.
Nemy M; Dyrba M; Brosseron F; Buerger K; Dechent P; Dobisch L; Ewers M; Fliessbach K; Glanz W; Goerss D; Heneka MT; Hetzer S; Incesoy EI; Janowitz D; Kilimann I; Laske C; Maier F; Munk MH; Perneczky R; Peters O; Preis L; Priller J; Rauchmann BS; Röske S; Roy N; Scheffler K; Schneider A; Schott BH; Spottke A; Spruth EJ; Wagner M; Wiltfang J; Yakupov R; Eriksdotter M; Westman E; Stepankova O; Vyslouzilova L; Düzel E; Jessen F; Teipel SJ; Ferreira D
Brain; 2023 May; 146(5):2075-2088. PubMed ID: 36288546
[TBL] [Abstract][Full Text] [Related]
5. Effect of cerebral small vessel disease on the integrity of cholinergic system in mild cognitive impairment patients: a longitudinal study.
Qiu T; Hong H; Zeng Q; Xu X; Wang Y; Zhu L; Zhang L; Li K; Dai S; Li X; Xie F; Zhang Y; Luo X;
J Neurol; 2024 May; 271(5):2704-2715. PubMed ID: 38381177
[TBL] [Abstract][Full Text] [Related]
6. Degeneration in Nucleus basalis of Meynert signals earliest stage of Alzheimer's disease progression.
Shafiee N; Fonov V; Dadar M; Spreng RN; Collins DL
Neurobiol Aging; 2024 Jul; 139():54-63. PubMed ID: 38608458
[TBL] [Abstract][Full Text] [Related]
7. Nucleus Basalis of Meynert Degeneration Predicts Cognitive Decline in Corticobasal Syndrome.
Urso D; Nigro S; Tafuri B; De Blasi R; Pereira JB; Logroscino G;
Biol Psychiatry; 2024 Jun; 95(11):1048-1054. PubMed ID: 38309321
[TBL] [Abstract][Full Text] [Related]
8. Nucleus basalis of Meynert degeneration predicts cognitive impairment in Parkinson's disease.
Wilson H; de Natale ER; Politis M
Handb Clin Neurol; 2021; 179():189-205. PubMed ID: 34225962
[TBL] [Abstract][Full Text] [Related]
9. Neuropsychiatric symptoms of cholinergic deficiency occur with degradation of the projections from the nucleus basalis of Meynert.
van Dalen JW; Caan MWA; van Gool WA; Richard E
Brain Imaging Behav; 2017 Dec; 11(6):1707-1719. PubMed ID: 27787708
[TBL] [Abstract][Full Text] [Related]
10. Are Linear Measurements of the Nucleus Basalis of Meynert Suitable as a Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer Disease?
Jethwa KD; Dhillon P; Meng D; Auer DP;
AJNR Am J Neuroradiol; 2019 Dec; 40(12):2039-2044. PubMed ID: 31727757
[TBL] [Abstract][Full Text] [Related]
11. Structural degeneration of the nucleus basalis of Meynert in mild cognitive impairment and Alzheimer's disease - Evidence from an MRI-based meta-analysis.
Mieling M; Meier H; Bunzeck N
Neurosci Biobehav Rev; 2023 Nov; 154():105393. PubMed ID: 37717861
[TBL] [Abstract][Full Text] [Related]
12. Pretangle pathology within cholinergic nucleus basalis neurons coincides with neurotrophic and neurotransmitter receptor gene dysregulation during the progression of Alzheimer's disease.
Tiernan CT; Ginsberg SD; He B; Ward SM; Guillozet-Bongaarts AL; Kanaan NM; Mufson EJ; Counts SE
Neurobiol Dis; 2018 Sep; 117():125-136. PubMed ID: 29859871
[TBL] [Abstract][Full Text] [Related]
13. HDAC2 dysregulation in the nucleus basalis of Meynert during the progression of Alzheimer's disease.
Mahady L; Nadeem M; Malek-Ahmadi M; Chen K; Perez SE; Mufson EJ
Neuropathol Appl Neurobiol; 2019 Jun; 45(4):380-397. PubMed ID: 30252960
[TBL] [Abstract][Full Text] [Related]
14. In vivo nucleus basalis of Meynert degeneration in mild cognitive impairment with Lewy bodies.
Schumacher J; Taylor JP; Hamilton CA; Firbank M; Cromarty RA; Donaghy PC; Roberts G; Allan L; Lloyd J; Durcan R; Barnett N; O'Brien JT; Thomas AJ
Neuroimage Clin; 2021; 30():102604. PubMed ID: 33711623
[TBL] [Abstract][Full Text] [Related]
15. Postural and gait symptoms in de novo Parkinson's disease patients correlate with cholinergic white matter pathology.
Nazmuddin M; van Dalen JW; Borra RJH; Stormezand GN; van der Horn HJ; van der Zee S; Boertien J; van Laar T
Parkinsonism Relat Disord; 2021 Dec; 93():43-49. PubMed ID: 34784526
[TBL] [Abstract][Full Text] [Related]
16. Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration.
Fernández-Cabello S; Kronbichler M; Van Dijk KRA; Goodman JA; Spreng RN; Schmitz TW;
Brain; 2020 Mar; 143(3):993-1009. PubMed ID: 32203580
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-132 and early growth response-1 in nucleus basalis of Meynert during the course of Alzheimer's disease.
Zhu QB; Unmehopa U; Bossers K; Hu YT; Verwer R; Balesar R; Zhao J; Bao AM; Swaab D
Brain; 2016 Mar; 139(Pt 3):908-21. PubMed ID: 26792551
[TBL] [Abstract][Full Text] [Related]
18. Nucleus basalis of Meynert damage and cognition in patients with multiple sclerosis.
Hildesheim FE; Benedict RHB; Zivadinov R; Dwyer MG; Fuchs T; Jakimovski D; Weinstock-Guttman B; Bergsland N
J Neurol; 2021 Dec; 268(12):4796-4808. PubMed ID: 33997915
[TBL] [Abstract][Full Text] [Related]
19. No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson's disease-related cognitive impairment.
Crockett RA; Wilkins KB; Aditham S; Brontë-Stewart HM
Neurobiol Dis; 2023 Sep; 185():106243. PubMed ID: 37524210
[TBL] [Abstract][Full Text] [Related]
20. Volume Loss of the Nucleus Basalis of Meynert is Associated with Atrophy of Innervated Regions in Mild Cognitive Impairment.
Cantero JL; Zaborszky L; Atienza M
Cereb Cortex; 2017 Aug; 27(8):3881-3889. PubMed ID: 27371762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
